China Medical & HealthCare Group Limited provided earnings guidance for the year ended June 30, 2016. For the period, the company is expected to record a substantial loss attributable to shareholders of the company as compared with a profit in 2015, mainly due to the realized and mark-to-market unrealized losses from investments held for trading and derivative financial instruments amid uncertain outlooks for economic growth, volatile financial and commodity markets, and worrying geopolitical tension, no net gain from the reversal of impairment on interest in a former associate and result on distribution in specie of shares of a former associate, which were partially off-set by the decrease in share of losses of associates.